Dissection of a fundamental step in gene activation using the HTLV-1-encoded Tax
使用 HTLV-1 编码的 Tax 剖析基因激活的基本步骤
基本信息
- 批准号:8699721
- 负责人:
- 金额:$ 5.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2015-06-17
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAdult T-Cell Leukemia/LymphomaAffinityArchitectureBindingBinding ProteinsBiological AssayCREB-binding proteinCREB1 geneCell physiologyCellsChromatinCommunitiesComplexCoupledCyclic AMP Response ElementCyclic AMP-Responsive DNA-Binding ProteinDNADiseaseDissectionEP300 geneEducationEventGene ActivationGene ExpressionGene Expression RegulationGenesGenetic TranscriptionHistone AcetylationHistonesHuman T-Cell Leukemia VirusesHuman T-lymphotropic virus 1In VitroIndividualInfectionInvestigationLaboratoriesMalignant - descriptorMalignant NeoplasmsMediatingMutationNucleosomesOncogene ProteinsPathway interactionsPost-Translational Protein ProcessingProcessProtein BindingProteinsRNA Polymerase IIRecruitment ActivityRegulationRetroviridaeRoleSiteStructureSurfaceTaxesTrainingTranscription CoactivatorTranscriptional ActivationViralViral Genescancer typedensitydesignexperiencehistone modificationhuman CREBBP proteinin vivointerestknowledge basemutantoutcome forecastpromoterpublic health relevancetool
项目摘要
DESCRIPTION (provided by applicant): The human T-cell leukemia virus type-1 (HTLV-1) is a retrovirus etiologically associated with Adult T-cell Leukemia (ATL). ATL is a malignant cancer associated with poor prognosis. Although 15-25 million people are estimated to be infected with HTLV, only 2-5 percent of these infections develop into ATL (for review see [2]). A major player in the malignant transformation of infected cells is the virally expressed oncoprotein, Tax. Tax is
a potent activator of transcription from the HTLV-1 promoter. Tax recruits the cellular proteins cAMP-response element binding protein (CREB) and p300/CREB-binding protein (CBP) to viral CRE sites located in the HTLV-1 LTR (for review see [1]). CBP/p300 is involved in numerous cellular pathways and understandably, deficiencies in CBP/p300 cause many types of cancer. Despite the participation of CBP/p300 in the regulation of many cellular pathways, little is known about the mechanism or its role in coactivator-mediated gene activation. We propose that a major activity of CBP/p300 is to recruit general transcriptional machinery to the promoter and that Tax stimulates this activity by binding to CBP/p300. This binding likely initiates structural changes in distinct domains of CBP/p300 that favor recruitment of general transcriptional machinery. Overall, the proposed studies will utilize interaction assays with targeted point mutants, individual domain isolations and deletions that target the interactions between Tax-CBP/p300. Competition and activity assays will enable us to functionally and biophysically characterize Tax-CBP/p300 interactions. Tax and CBP/p300 mutants developed will also be used to investigate structural changes in various domains of CBP/p300 and how these binding- induced changes relate to transcriptional machinery recruitment and activity. These studies have implications for viral and cellular mechanisms of activation, adding to the generally weak knowledge base on the role of coactivator contribution to this process.
描述(由申请方提供):人T细胞白血病病毒1型(HTLV-1)是一种与成人T细胞白血病(ATL)病因相关的逆转录病毒。ATL是一种预后不良的恶性肿瘤。尽管估计有1500万至2500万人感染HTLV,但这些感染中只有2%至5%发展为ATL(综述见[2])。病毒表达的癌蛋白Tax是感染细胞恶性转化的主要参与者。税是
HTLV-1启动子转录的有效激活剂。Tax将细胞蛋白cAMP反应元件结合蛋白(CREB)和p300/CREB结合蛋白(CBP)募集到位于HTLV-1 LTR中的病毒CRE位点(综述见[1])。CBP/p300参与许多细胞途径,可以理解的是,CBP/p300的缺陷会导致许多类型的癌症。尽管CBP/p300参与了许多细胞通路的调节,但其在辅激活因子介导的基因激活中的机制或作用知之甚少。我们建议CBP/p300的一个主要活动是招募一般的转录机制的启动子和税收刺激这种活动结合CBP/p300。这种结合可能引发CBP/p300不同结构域的结构变化,有利于一般转录机制的募集。总体而言,拟定研究将利用靶向点突变体、单个结构域分离和缺失的相互作用试验,靶向Tax-CBP/p300之间的相互作用。竞争和活性测定将使我们能够从功能和生物药理学上表征Tax-CBP/p300相互作用。开发的Tax和CBP/p300突变体也将用于研究CBP/p300的各个结构域中的结构变化以及这些结合诱导的变化如何与转录机器募集和活性相关。这些研究对病毒和细胞的激活机制有影响,增加了对辅激活因子在此过程中的作用的普遍薄弱的知识基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alisha D Howard其他文献
Examination of the interactions between the HTLV-1-encoded Tax oncoprotein and the cellular coactivators CBP/p300
- DOI:
10.1186/1742-4690-11-s1-p130 - 发表时间:
2014-01-07 - 期刊:
- 影响因子:3.900
- 作者:
Alisha D Howard;Jennifer K Nyborg - 通讯作者:
Jennifer K Nyborg
Alisha D Howard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alisha D Howard', 18)}}的其他基金
Dissection of a fundamental step in gene activation using the HTLV-1-encoded Tax
使用 HTLV-1 编码的 Tax 剖析基因激活的基本步骤
- 批准号:
8669726 - 财政年份:2012
- 资助金额:
$ 5.1万 - 项目类别:
Dissection of a fundamental step in gene activation using the HTLV-1-encoded Tax
使用 HTLV-1 编码的 Tax 剖析基因激活的基本步骤
- 批准号:
8398891 - 财政年份:2012
- 资助金额:
$ 5.1万 - 项目类别:
相似海外基金
Pathophysiology of Adult T-cell leukemia/lymphoma
成人 T 细胞白血病/淋巴瘤的病理生理学
- 批准号:
10609828 - 财政年份:2022
- 资助金额:
$ 5.1万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 5.1万 - 项目类别:
Pathophysiology of Adult T-cell leukemia/lymphoma
成人 T 细胞白血病/淋巴瘤的病理生理学
- 批准号:
10369933 - 财政年份:2022
- 资助金额:
$ 5.1万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10518751 - 财政年份:2022
- 资助金额:
$ 5.1万 - 项目类别:
Adoptive immunotherapy for adult T-cell leukemia/lymphoma with ex vivo expanded multi-tumor associated antigen specific cytotoxic T-cells
使用离体扩增的多肿瘤相关抗原特异性细胞毒性 T 细胞对成人 T 细胞白血病/淋巴瘤进行过继免疫治疗
- 批准号:
20K17375 - 财政年份:2020
- 资助金额:
$ 5.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of a novel drug discovery platform for adult T-cell leukemia/lymphoma using PROTAC technology
利用PROTAC技术建立成人T细胞白血病/淋巴瘤新药发现平台
- 批准号:
20K08736 - 财政年份:2020
- 资助金额:
$ 5.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a multiplex RT-PCR method to assess the risk of stage progression in adult T-cell leukemia/lymphoma
开发多重 RT-PCR 方法来评估成人 T 细胞白血病/淋巴瘤分期进展的风险
- 批准号:
20K07700 - 财政年份:2020
- 资助金额:
$ 5.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of genomic alterations and the clinicopathological significance in adult T-cell leukemia/lymphoma
阐明成人 T 细胞白血病/淋巴瘤的基因组改变及其临床病理学意义
- 批准号:
20K16177 - 财政年份:2020
- 资助金额:
$ 5.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Screening of Promising Chemotherapeutic Candidates from Plants against Human Adult T-Cell Leukemia/Lymphoma
从植物中筛选有前途的抗成人 T 细胞白血病/淋巴瘤的化疗候选药物
- 批准号:
19K16403 - 财政年份:2019
- 资助金额:
$ 5.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A new diagnostic algorithm using biopsy specimens in adult T-cell leukemia/lymphoma: combination of RNA in situ hybridization and quantitative PCR for HTLV-1
使用成人 T 细胞白血病/淋巴瘤活检标本的新诊断算法:结合 RNA 原位杂交和 HTLV-1 定量 PCR
- 批准号:
19K07438 - 财政年份:2019
- 资助金额:
$ 5.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)